PlainRecalls
FDA Drug Moderate Class II Terminated

Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901

Reported: September 18, 2019 Initiated: August 30, 2019 #D-1849-2019

Product Description

Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901

Reason for Recall

Lack of assurance of sterility.

Details

Distribution
Continental U.S. and Puerto Rico
Location
Melbourne, FL

Frequently Asked Questions

What product was recalled?
Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901. Recalled by Pacifico National, Inc. dba AmEx Pharmacy.
Why was this product recalled?
Lack of assurance of sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 18, 2019. Severity: Moderate. Recall number: D-1849-2019.